Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyBiologicalProcess	RNA splicing	CCNL2 PPARGC1A SREK1 SRSF7 RBMXL1 CDK12 SRSF8 SRRM4 RBMX RSRC1 CCNL1 ZRANB2	8.16e-11	502	39	12	GO:0008380
GeneOntologyBiologicalProcess	mRNA processing	PPARGC1A SREK1 SRSF7 RBMXL1 CDK12 SRSF8 SRRM4 RBMX RSRC1 PHRF1 ZRANB2	3.81e-09	551	39	11	GO:0006397
GeneOntologyBiologicalProcess	regulation of RNA splicing	CCNL2 SRSF7 RBMXL1 CDK12 SRRM4 RBMX CCNL1	1.09e-07	207	39	7	GO:0043484
GeneOntologyBiologicalProcess	RNA processing	CCNL2 PPARGC1A SREK1 CHERP SRSF7 RBMXL1 CDK12 SRSF8 SRRM4 RBMX RSRC1 CCNL1 PHRF1 ZRANB2	2.91e-07	1500	39	14	GO:0006396
GeneOntologyBiologicalProcess	mRNA metabolic process	PPARGC1A SREK1 SRSF7 RBMXL1 CDK12 SRSF8 SRRM4 RBMX RSRC1 PHRF1 ZRANB2	6.74e-07	917	39	11	GO:0016071
GeneOntologyBiologicalProcess	mRNA splicing, via spliceosome	SRSF7 RBMXL1 SRSF8 SRRM4 RBMX RSRC1	5.27e-05	358	39	6	GO:0000398
GeneOntologyBiologicalProcess	RNA splicing, via transesterification reactions with bulged adenosine as nucleophile	SRSF7 RBMXL1 SRSF8 SRRM4 RBMX RSRC1	5.27e-05	358	39	6	GO:0000377
GeneOntologyBiologicalProcess	RNA splicing, via transesterification reactions	SRSF7 RBMXL1 SRSF8 SRRM4 RBMX RSRC1	5.61e-05	362	39	6	GO:0000375
GeneOntologyBiologicalProcess	regulation of mRNA splicing, via spliceosome	SRSF7 RBMXL1 SRRM4 RBMX	1.01e-04	129	39	4	GO:0048024
GeneOntologyBiologicalProcess	regulation of mRNA processing	SRSF7 RBMXL1 SRRM4 RBMX	2.21e-04	158	39	4	GO:0050684
GeneOntologyBiologicalProcess	alternative mRNA splicing, via spliceosome	SRRM4 RBMX RSRC1	4.47e-04	79	39	3	GO:0000380
GeneOntologyCellularComponent	nuclear speck	CCNL2 SETD1A SREK1 SRSF7 RBBP6 CDK12 BCLAF1 GLI2 SRSF8 RSRC1 CCNL1	2.51e-10	431	39	11	GO:0016607
GeneOntologyCellularComponent	nuclear body	CCNL2 PPARGC1A SETD1A SREK1 SRSF7 RBBP6 CDK12 BCLAF1 GLI2 SRSF8 RSRC1 CCNL1	5.22e-08	903	39	12	GO:0016604
GeneOntologyCellularComponent	supraspliceosomal complex	RBMXL1 RBMX	2.03e-05	4	39	2	GO:0044530
GeneOntologyCellularComponent	cyclin-dependent protein kinase holoenzyme complex	CCNL2 CDK12 CCNL1	2.00e-04	61	39	3	GO:0000307
GeneOntologyCellularComponent	euchromatin	PPARGC1A SETD1A RBMX	3.28e-04	72	39	3	GO:0000791
HumanPheno	Periorbital fullness	SETD2 CHD1 SPEN RBMX	1.68e-06	45	11	4	HP:0000629
Domain	RRM_1	PPARGC1A SETD1A SREK1 SRSF7 RBMXL1 SPEN SRSF8 RBMX	7.59e-09	208	38	8	PF00076
Domain	RRM	PPARGC1A SETD1A SREK1 SRSF7 RBMXL1 SPEN SRSF8 RBMX	1.06e-08	217	38	8	SM00360
Domain	RRM_dom	PPARGC1A SETD1A SREK1 SRSF7 RBMXL1 SPEN SRSF8 RBMX	1.50e-08	227	38	8	IPR000504
Domain	RRM	PPARGC1A SETD1A SREK1 SRSF7 RBMXL1 SPEN SRSF8 RBMX	1.67e-08	230	38	8	PS50102
Domain	-	PPARGC1A SETD1A SREK1 SRSF7 RBMXL1 SPEN SRSF8 RBMX	2.64e-08	244	38	8	3.30.70.330
Domain	Nucleotide-bd_a/b_plait	PPARGC1A SETD1A SREK1 SRSF7 RBMXL1 SPEN SRSF8 RBMX	4.07e-08	258	38	8	IPR012677
Domain	GAR	GAS2L1 MACF1	6.02e-05	6	38	2	PS51460
Domain	-	GAS2L1 MACF1	6.02e-05	6	38	2	3.30.920.20
Domain	GAS_dom	GAS2L1 MACF1	6.02e-05	6	38	2	IPR003108
Domain	GAS2	GAS2L1 MACF1	6.02e-05	6	38	2	PF02187
Domain	GAS2	GAS2L1 MACF1	6.02e-05	6	38	2	SM00243
Domain	RBM1CTR	RBMXL1 RBMX	1.12e-04	8	38	2	PF08081
Domain	RBM1CTR	RBMXL1 RBMX	1.12e-04	8	38	2	IPR012604
Domain	Cyclin_L/T	CCNL2 CCNL1	1.12e-04	8	38	2	IPR015429
Domain	CH	GAS2L1 MACF1 VAV2	3.11e-04	65	38	3	SM00033
Domain	CH	GAS2L1 MACF1 VAV2	3.87e-04	70	38	3	PF00307
Domain	-	GAS2L1 MACF1 VAV2	4.04e-04	71	38	3	1.10.418.10
Domain	CH	GAS2L1 MACF1 VAV2	4.38e-04	73	38	3	PS50021
Domain	CH-domain	GAS2L1 MACF1 VAV2	4.74e-04	75	38	3	IPR001715
Domain	Post-SET_dom	SETD1A SETD2	4.75e-04	16	38	2	IPR003616
Domain	PostSET	SETD1A SETD2	4.75e-04	16	38	2	SM00508
Domain	POST_SET	SETD1A SETD2	4.75e-04	16	38	2	PS50868
Domain	Cyclin_C-dom	CCNL2 CCNL1	5.38e-04	17	38	2	IPR004367
Domain	Cyclin_C	CCNL2 CCNL1	5.38e-04	17	38	2	PF02984
Domain	Cyclin_C	CCNL2 CCNL1	5.38e-04	17	38	2	SM01332
Domain	G_patch	GPATCH8 CHERP	9.93e-04	23	38	2	SM00443
Domain	G_patch_dom	GPATCH8 CHERP	9.93e-04	23	38	2	IPR000467
Domain	RRM_dom_euk	RBMXL1 RBMX	9.93e-04	23	38	2	IPR003954
Domain	G-patch	GPATCH8 CHERP	9.93e-04	23	38	2	PF01585
Domain	G_PATCH	GPATCH8 CHERP	9.93e-04	23	38	2	PS50174
Domain	RRM_1	RBMXL1 RBMX	9.93e-04	23	38	2	SM00361
Domain	zf-CCHC	SRSF7 RBBP6	9.93e-04	23	38	2	PF00098
Domain	-	SRSF7 RBBP6	1.27e-03	26	38	2	4.10.60.10
Domain	CYCLINS	CCNL2 CCNL1	1.47e-03	28	38	2	PS00292
Domain	Cyclin_N	CCNL2 CCNL1	2.05e-03	33	38	2	IPR006671
Domain	Cyclin_N	CCNL2 CCNL1	2.05e-03	33	38	2	PF00134
Domain	ZF_CCHC	SRSF7 RBBP6	2.30e-03	35	38	2	PS50158
Domain	CYCLIN	CCNL2 CCNL1	2.71e-03	38	38	2	SM00385
Domain	-	CCNL2 CCNL1	2.99e-03	40	38	2	1.10.472.10
Domain	SET	SETD1A SETD2	3.14e-03	41	38	2	PF00856
Domain	Cyclin-like	CCNL2 CCNL1	3.45e-03	43	38	2	IPR013763
Domain	SET	SETD1A SETD2	3.94e-03	46	38	2	SM00317
Domain	SET_dom	SETD1A SETD2	4.64e-03	50	38	2	IPR001214
Domain	SET	SETD1A SETD2	4.64e-03	50	38	2	PS50280
Domain	Quinoprotein_ADH-like_supfam	WDR27 EIF2AK3	5.20e-03	53	38	2	IPR011047
Domain	ZnF_C2HC	SRSF7 RBBP6	5.59e-03	55	38	2	SM00343
Domain	Znf_CCHC	SRSF7 RBBP6	5.59e-03	55	38	2	IPR001878
Pathway	REACTOME_RHOBTB1_GTPASE_CYCLE	SPEN RBBP6 RBMX	1.21e-05	23	28	3	M41817
Pathway	REACTOME_RHOBTB1_GTPASE_CYCLE	SPEN RBBP6 RBMX	1.57e-05	25	28	3	MM15608
Pathway	WP_MRNA_PROCESSING	PPARGC1A SREK1 SRSF7 RBMXL1 SPEN BCLAF1 RBMX	2.16e-05	451	28	7	MM15946
Pathway	REACTOME_RHOBTB_GTPASE_CYCLE	SPEN RBBP6 RBMX	4.40e-05	35	28	3	M41738
Pathway	REACTOME_RHOBTB_GTPASE_CYCLE	SPEN RBBP6 RBMX	5.21e-05	37	28	3	MM15683
Pathway	KEGG_SPLICEOSOME	CHERP SRSF7 SRSF8 RBMX	1.09e-04	127	28	4	M2044
Pathway	REACTOME_MRNA_SPLICING	CHERP SRSF7 SRSF8 RBMX	7.67e-04	212	28	4	M14033
Pubmed	RNA-binding proteins with basic-acidic dipeptide (BAD) domains self-assemble and aggregate in Alzheimer's disease.	NKTR SREK1 GPATCH8 CHERP SRSF7 RBMXL1 RBBP6 CDK12 BCLAF1 SRSF8 RBMX RSRC1 ZRANB2	7.34e-13	713	40	13	29802200
Pubmed	MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.	NEFM MACF1 SETD2 SREK1 GPATCH8 CHERP SRSF7 RBMXL1 SPEN RBBP6 CDK12 BCLAF1 RBMX ZRANB2	7.99e-12	1082	40	14	38697112
Pubmed	SETD1A Methyltransferase Is Physically and Functionally Linked to the DNA Damage Repair Protein RAD18.	LENG8 SETD1A RBMXL1 SPEN RBBP6 CDK12 BCLAF1 SRSF8 ZRANB2	1.04e-11	251	40	9	31076518
Pubmed	The protein interaction landscape of the human CMGC kinase group.	SETD2 SREK1 GPATCH8 CHERP SRSF7 RBBP6 CDK12 BCLAF1 SRSF8 RBMX RSRC1 ZRANB2	1.24e-11	695	40	12	23602568
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	SETD2 GPATCH8 SRSF7 SPEN RBBP6 CDK12 BCLAF1 RBMX LRRFIP1 CCNL1 PHRF1 ZRANB2	4.28e-11	774	40	12	15302935
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	LENG8 MACF1 SETD2 CHD1 SREK1 GPATCH8 PCNX3 SPEN RBBP6 CDK12 GOSR1 RSRC1 CCNL1 PHRF1 ZRANB2	4.38e-11	1497	40	15	31527615
Pubmed	Characterizing ZC3H18, a Multi-domain Protein at the Interface of RNA Production and Destruction Decisions.	LENG8 SRSF7 RBMXL1 SPEN RBBP6 CDK12 BCLAF1 SRSF8 RBMX RSRC1 ZRANB2	4.36e-10	731	40	11	29298432
Pubmed	SNIP1 Recruits TET2 to Regulate c-MYC Target Genes and Cellular DNA Damage Response.	NKTR CHERP SRSF7 PCNX3 RBMXL1 BCLAF1 PHRF1 ZRANB2	5.31e-10	259	40	8	30404004
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	SETD2 NKTR GPATCH8 CHERP SRSF7 SPEN RBBP6 BCLAF1 SRSF8 RBMX GOSR1 RSRC1 PHRF1	1.16e-09	1294	40	13	30804502
Pubmed	The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts.	MACF1 SREK1 GPATCH8 CHERP SRSF7 SPEN RBBP6 BCLAF1 SRSF8 RBMX ZRANB2	1.23e-09	807	40	11	22681889
Pubmed	Regulation of alternative splicing by SRrp86 and its interacting proteins.	SREK1 SRSF7 SRSF8 RBMX ZRANB2	6.22e-09	57	40	5	14559993
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	LENG8 SETD2 CHD1 SREK1 CHERP SRSF7 SPEN RBBP6 CDK12 BCLAF1 RBMX	6.98e-09	954	40	11	36373674
Pubmed	Comparative interactome analysis of α-arrestin families in human and Drosophila.	SETD1A GPATCH8 CHERP SRSF7 SPEN RBBP6 BCLAF1	6.46e-08	313	40	7	38270169
Pubmed	Delineating the HMGB1 and HMGB2 interactome in prostate and ovary epithelial cells and its relationship with cancer.	NKTR SRSF7 BCLAF1 RBMX CCNL1 ZRANB2	7.59e-08	188	40	6	29721183
Pubmed	Folate receptor α increases chemotherapy resistance through stabilizing MDM2 in cooperation with PHB2 that is overcome by MORAb-202 in gastric cancer.	SREK1 SRSF7 RBBP6 SRSF8 RBMX RSRC1	1.30e-07	206	40	6	34185411
Pubmed	The E3 ubiquitin ligase UBR5 interacts with the H/ACA ribonucleoprotein complex and regulates ribosomal RNA biogenesis in embryonic stem cells.	CCNL2 SREK1 CHERP CDK12 CCNL1	1.31e-07	104	40	5	31365120
Pubmed	SR protein kinases promote splicing of nonconsensus introns.	MACF1 SRSF7 SPEN RBBP6 CDK12 BCLAF1 RBMX	1.70e-07	361	40	7	26167880
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	NEFM SETD1A SETD2 SPEN RBBP6 CDK12 BCLAF1 LRRFIP1	1.81e-07	549	40	8	38280479
Pubmed	Interactome analyses revealed that the U1 snRNP machinery overlaps extensively with the RNAP II machinery and contains multiple ALS/SMA-causative proteins.	GPATCH8 CHERP SRSF7 BCLAF1 RBMX RSRC1	3.52e-07	244	40	6	29884807
Pubmed	Combinatorial targeting of a chromatin complex comprising Dot1L, menin and the tyrosine kinase BAZ1B reveals a new therapeutic vulnerability of endocrine therapy-resistant breast cancer.	CHD1 SREK1 CHERP SRSF7 RBBP6 BCLAF1 RBMX RSRC1 ZRANB2	4.01e-07	847	40	9	35850772
Pubmed	Automated yeast two-hybrid screening for nuclear receptor-interacting proteins.	PPARGC1A MACF1 REPS2 HNF4A SPEN	4.48e-07	133	40	5	15604093
Pubmed	Reciprocal interaction between SIRT6 and APC/C regulates genomic stability.	LENG8 SETD1A SETD2 NKTR GPATCH8 EIF2AK3 BCLAF1	6.43e-07	440	40	7	34244565
Pubmed	Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells.	SRSF7 SPEN RBBP6 CDK12 BCLAF1 ZRANB2	8.38e-07	283	40	6	30585729
Pubmed	Loss of SETD2 Induces a Metabolic Switch in Renal Cell Carcinoma Cell Lines toward Enhanced Oxidative Phosphorylation.	PPARGC1A SETD2	1.29e-06	2	40	2	30406665
Pubmed	Cisplatin Enhances Hepatitis B Virus Replication and PGC-1α Expression through Endoplasmic Reticulum Stress.	PPARGC1A HNF4A	1.29e-06	2	40	2	29472690
Pubmed	Epigenotype-genotype-phenotype correlations in SETD1A and SETD2 chromatin disorders.	SETD1A SETD2	1.29e-06	2	40	2	37166351
Pubmed	Regulation of hepatic fasting response by PPARgamma coactivator-1alpha (PGC-1): requirement for hepatocyte nuclear factor 4alpha in gluconeogenesis.	PPARGC1A HNF4A	1.29e-06	2	40	2	12651943
Pubmed	Distinct amino acid residues may be involved in coactivator and ligand interactions in hepatocyte nuclear factor-4alpha.	PPARGC1A HNF4A	1.29e-06	2	40	2	15826954
Pubmed	cAMP-mediated regulation of HNF-4alpha depends on the level of coactivator PGC-1alpha.	PPARGC1A HNF4A	1.29e-06	2	40	2	20670916
Pubmed	Partnership of PGC-1alpha and HNF4alpha in the regulation of lipoprotein metabolism.	PPARGC1A HNF4A	1.29e-06	2	40	2	16574644
Pubmed	Impaired plasma membrane localization of ubiquitin ligase complex underlies 3-M syndrome development.	MACF1 SETD2 CHD1 RBBP6 PLEKHA3 PHRF1 ZRANB2	1.43e-06	496	40	7	31343991
Pubmed	MYC multimers shield stalled replication forks from RNA polymerase.	LENG8 CHD1 SREK1 GPATCH8 CHERP SRSF7 BCLAF1 RBMX ZRANB2	1.45e-06	989	40	9	36424410
Pubmed	Nuclear actin interactome analysis links actin to KAT14 histone acetyl transferase and mRNA splicing.	LENG8 CHERP RBBP6 CDK12 BCLAF1 LRRFIP1 ZRANB2	1.63e-06	506	40	7	30890647
Pubmed	BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression.	SETD1A CHD1 NKTR SREK1 CHERP SRSF7 RBBP6 SRSF8 RBMX RSRC1	1.77e-06	1318	40	10	30463901
Pubmed	Tagging genes with cassette-exchange sites.	MACF1 GPATCH8 CHERP CDK12 GLI2 PHRF1	2.22e-06	335	40	6	15741177
Pubmed	Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism.	LENG8 SETD1A CHD1 SPEN RBBP6 BCLAF1	2.46e-06	341	40	6	32971831
Pubmed	HDLBP Promotes Hepatocellular Carcinoma Proliferation and Sorafenib Resistance by Suppressing Trim71-dependent RAF1 Degradation.	LENG8 PIMREG NKTR SRSF7 CDK12 BCLAF1 SRSF8 RBMX RSRC1 LRRFIP1	2.52e-06	1371	40	10	36244648
Pubmed	A genome-wide in situ hybridization map of RNA-binding proteins reveals anatomically restricted expression in the developing mouse brain.	PPARGC1A SREK1 SRSF7 RBMXL1 SPEN RBMX	2.72e-06	347	40	6	16033648
Pubmed	Two novel cis-elements involved in hepatocyte nuclear factor 4α regulation of acyl-coenzyme A:cholesterol acyltransferase 2 expression.	PPARGC1A HNF4A	3.87e-06	3	40	2	22155889
Pubmed	Characterization of cyclin L1 and L2 interactions with CDK11 and splicing factors: influence of cyclin L isoforms on splice site selection.	CCNL2 CCNL1	3.87e-06	3	40	2	18216018
Pubmed	Characterization of novel peroxisome proliferator-activated receptor γ coactivator-1α (PGC-1α) isoform in human liver.	PPARGC1A HNF4A	3.87e-06	3	40	2	22009745
Pubmed	Transcriptional control of CBX5 by the RNA binding proteins RBMX and RBMXL1 maintains chromatin state in myeloid leukemia.	RBMXL1 RBMX	3.87e-06	3	40	2	34458856
Pubmed	Association of genes involved in bile acid synthesis with the progression of primary biliary cirrhosis in Japanese patients.	PPARGC1A HNF4A	3.87e-06	3	40	2	23354620
Pubmed	PGC1α regulates ACMSD expression through cooperation with HNF4α.	PPARGC1A HNF4A	3.87e-06	3	40	2	30232574
Pubmed	RBMX is a novel hepatic transcriptional regulator of SREBP-1c gene response to high-fructose diet.	RBMXL1 RBMX	3.87e-06	3	40	2	17188681
Pubmed	Expression of the mouse Macf2 gene during inner ear development.	NEFM MACF1	3.87e-06	3	40	2	12399109
Pubmed	Apolipoprotein A-IV is regulated by nutritional and metabolic stress: involvement of glucocorticoids, HNF-4 alpha, and PGC-1 alpha.	PPARGC1A HNF4A	3.87e-06	3	40	2	16929032
Pubmed	Ligand-activated pregnane X receptor interferes with HNF-4 signaling by targeting a common coactivator PGC-1alpha. Functional implications in hepatic cholesterol and glucose metabolism.	PPARGC1A HNF4A	3.87e-06	3	40	2	15322103
Pubmed	DAX-1 acts as a novel corepressor of orphan nuclear receptor HNF4alpha and negatively regulates gluconeogenic enzyme gene expression.	PPARGC1A HNF4A	3.87e-06	3	40	2	19651776
Pubmed	Functional inhibitory cross-talk between constitutive androstane receptor and hepatic nuclear factor-4 in hepatic lipid/glucose metabolism is mediated by competition for binding to the DR1 motif and to the common coactivators, GRIP-1 and PGC-1alpha.	PPARGC1A HNF4A	3.87e-06	3	40	2	16492670
Pubmed	RBMY evolved on the Y chromosome from a ubiquitously transcribed X-Y identical gene.	RBMXL1 RBMX	3.87e-06	3	40	2	10391207
Pubmed	Large-scale study of the -232C > G polymorphism of PCK1 in Type 2 diabetes.	PPARGC1A HNF4A	3.87e-06	3	40	2	16978381
Pubmed	Hepatocyte nuclear factor-4alpha regulates the human apolipoprotein AV gene: identification of a novel response element and involvement in the control by peroxisome proliferator-activated receptor-gamma coactivator-1alpha, AMP-activated protein kinase, and mitogen-activated protein kinase pathway.	PPARGC1A HNF4A	3.87e-06	3	40	2	16051671
Pubmed	CDK13/CDC2L5 interacts with L-type cyclins and regulates alternative splicing.	CCNL2 CCNL1	3.87e-06	3	40	2	17261272
Pubmed	Hepatocyte nuclear factor-4 alpha mediates the stimulatory effect of peroxisome proliferator-activated receptor gamma co-activator-1 alpha (PGC-1 alpha) on glucose-6-phosphatase catalytic subunit gene transcription in H4IIE cells.	PPARGC1A HNF4A	3.87e-06	3	40	2	12416993
Pubmed	Multiple binding modes between HNF4alpha and the LXXLL motifs of PGC-1alpha lead to full activation.	PPARGC1A HNF4A	3.87e-06	3	40	2	19846556
Pubmed	Fasting-induced hepatic production of DHEA is regulated by PGC-1alpha, ERRalpha, and HNF4alpha.	PPARGC1A HNF4A	3.87e-06	3	40	2	19389810
Pubmed	Characterization of cyclin L1 as an immobile component of the splicing factor compartment.	CCNL2 CCNL1	3.87e-06	3	40	2	17494991
Pubmed	Essential roles for the splicing regulator nSR100/SRRM4 during nervous system development.	NEFM VAV2 SRRM4	6.19e-06	31	40	3	25838543
Pubmed	Characterization of gene regulation and protein interaction networks for Matrin 3 encoding mutations linked to amyotrophic lateral sclerosis and myopathy.	SRSF7 RBMXL1 BCLAF1 RBMX	7.65e-06	109	40	4	29511296
Pubmed	Lower expression of HNF4α and PGC1α might impair rifampicin-mediated CYP3A4 induction under conditions where PXR is overexpressed in human fetal liver cells.	PPARGC1A HNF4A	7.73e-06	4	40	2	22333269
Pubmed	CDK11 complexes promote pre-mRNA splicing.	SRSF7 CCNL1	7.73e-06	4	40	2	12501247
Pubmed	CDK11(p58) kinase activity is required to protect sister chromatid cohesion at centromeres in mitosis.	CCNL2 CCNL1	7.73e-06	4	40	2	24436071
Pubmed	Functional interaction of hepatic nuclear factor-4 and peroxisome proliferator-activated receptor-gamma coactivator 1alpha in CYP7A1 regulation is inhibited by a key lipogenic activator, sterol regulatory element-binding protein-1c.	PPARGC1A HNF4A	7.73e-06	4	40	2	17636037
Pubmed	SREBP-1 interacts with hepatocyte nuclear factor-4 alpha and interferes with PGC-1 recruitment to suppress hepatic gluconeogenic genes.	PPARGC1A HNF4A	7.73e-06	4	40	2	14722127
Pubmed	Increased expression of a 58-kDa protein kinase leads to changes in the CHO cell cycle.	CCNL2 CCNL1	7.73e-06	4	40	2	2217177
Pubmed	Regulation of constitutive androstane receptor and its target genes by fasting, cAMP, hepatocyte nuclear factor alpha, and the coactivator peroxisome proliferator-activated receptor gamma coactivator-1alpha.	PPARGC1A HNF4A	7.73e-06	4	40	2	16825189
Pubmed	SAFB1, an RBMX-binding protein, is a newly identified regulator of hepatic SREBP-1c gene.	RBMXL1 RBMX	7.73e-06	4	40	2	19403048
Pubmed	Threshold levels of hepatocyte nuclear factor 6 (HNF-6) acting in synergy with HNF-4 and PGC-1alpha are required for time-specific gene expression during liver development.	PPARGC1A HNF4A	7.73e-06	4	40	2	16880515
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	NEFM MACF1 CHD1 CHERP SPEN RBMX PHRF1	8.67e-06	653	40	7	22586326
Pubmed	Proteomic Analysis of the EWS-Fli-1 Interactome Reveals the Role of the Lysosome in EWS-Fli-1 Turnover.	GPATCH8 SRSF7 RBBP6 CDK12 PHRF1 ZRANB2	8.68e-06	425	40	6	24999758
Pubmed	SMYD3 Impedes Small Cell Lung Cancer Sensitivity to Alkylation Damage through RNF113A Methylation-Phosphorylation Cross-talk.	CHD1 SREK1 CHERP SRSF7 RBBP6 BCLAF1 ZRANB2	8.84e-06	655	40	7	35819319
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	LENG8 MACF1 SETD2 CHD1 CHERP RBBP6 CDK12 BCLAF1	9.42e-06	934	40	8	33916271
Pubmed	Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells.	GPATCH8 SRSF7 SPEN RBBP6 BCLAF1 RSRC1 ZRANB2	9.76e-06	665	40	7	30457570
Pubmed	PTPN14 regulates Roquin2 stability by tyrosine dephosphorylation.	SREK1 CHERP SRSF7 RBBP6 CDK12 BCLAF1 RBMX	1.11e-05	678	40	7	30209976
Pubmed	Circular RNA circPVT1 promotes nasopharyngeal carcinoma metastasis via the β-TrCP/c-Myc/SRSF1 positive feedback loop.	SRSF7 BCLAF1 SRSF8 RBMX ZRANB2	1.19e-05	260	40	5	36199071
Pubmed	Dopamine and glutamate induce distinct striatal splice forms of Ania-6, an RNA polymerase II-associated cyclin.	CCNL2 CCNL1	1.29e-05	5	40	2	11683997
Pubmed	A Prospero-related homeodomain protein is a novel co-regulator of hepatocyte nuclear factor 4alpha that regulates the cholesterol 7alpha-hydroxylase gene.	PPARGC1A HNF4A	1.29e-05	5	40	2	16488887
Pubmed	RNA-binding protein SPEN controls hepatocyte maturation via regulating Hnf4α expression during liver development.	HNF4A SPEN	1.29e-05	5	40	2	36577249
Pubmed	CDK11(p58) protein kinase activity is associated with Bcl-2 down-regulation in pro-apoptosis pathway.	CCNL2 CCNL1	1.29e-05	5	40	2	17516030
Pubmed	Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1.	PPARGC1A HNF4A	1.29e-05	5	40	2	15744310
Pubmed	Loss-of-Function Variants in PPP1R12A: From Isolated Sex Reversal to Holoprosencephaly Spectrum and Urogenital Malformations.	CHD1 GLI2	1.29e-05	5	40	2	31883643
Pubmed	Rifampicin induction of CYP3A4 requires pregnane X receptor cross talk with hepatocyte nuclear factor 4alpha and coactivators, and suppression of small heterodimer partner gene expression.	PPARGC1A HNF4A	1.29e-05	5	40	2	16455805
Pubmed	Insulin-regulated hepatic gluconeogenesis through FOXO1-PGC-1alpha interaction.	PPARGC1A HNF4A	1.29e-05	5	40	2	12754525
Pubmed	Mechanism of rifampicin and pregnane X receptor inhibition of human cholesterol 7 alpha-hydroxylase gene transcription.	PPARGC1A HNF4A	1.29e-05	5	40	2	15331348
Pubmed	Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation.	LENG8 GPATCH8 CDK12 RBMX GOSR1 ZRANB2	1.31e-05	457	40	6	32344865
Pubmed	ATG5 is required for B cell polarization and presentation of particulate antigens.	NKTR GPATCH8 RBBP6 CDK12 RBMX RSRC1 ZRANB2	1.37e-05	701	40	7	30196744
Pubmed	Insights into the ubiquitin-proteasome system of human embryonic stem cells.	SREK1 CHERP CDK12 LRRFIP1 CCNL1	1.41e-05	269	40	5	29511261
Pubmed	Matrix-screening reveals a vast potential for direct protein-protein interactions among RNA binding proteins.	SREK1 SRSF7 RBBP6 SRSF8 SRRM4 RBMX ZRANB2	1.67e-05	723	40	7	34133714
Pubmed	Activated sterol regulatory element-binding protein-2 suppresses hepatocyte nuclear factor-4-mediated Cyp3a11 expression in mouse liver.	PPARGC1A HNF4A	1.93e-05	6	40	2	20926756
Pubmed	Activation of farnesoid X receptor promotes triglycerides lowering by suppressing phospholipase A2 G12B expression.	PPARGC1A HNF4A	1.93e-05	6	40	2	27471003
Pubmed	Peroxisome proliferator-activated receptor gamma coactivator 1beta (PGC-1beta ), a novel PGC-1-related transcription coactivator associated with host cell factor.	PPARGC1A HNF4A	1.93e-05	6	40	2	11733490
Pubmed	Transcriptional activation of CYP2C9, CYP1A1, and CYP1A2 by hepatocyte nuclear factor 4alpha requires coactivators peroxisomal proliferator activated receptor-gamma coactivator 1alpha and steroid receptor coactivator 1.	PPARGC1A HNF4A	1.93e-05	6	40	2	16882880
Pubmed	A comprehensive SARS-CoV-2-human protein-protein interactome reveals COVID-19 pathobiology and potential host therapeutic targets.	SETD2 CHERP RBMXL1 BCLAF1 RBMX CCNL1	2.25e-05	503	40	6	36217030
Pubmed	A probability-based approach for high-throughput protein phosphorylation analysis and site localization.	SPEN RBBP6 CDK12 BCLAF1 RBMX LRRFIP1	2.25e-05	503	40	6	16964243
Pubmed	CHD1 associates with NCoR and histone deacetylase as well as with RNA splicing proteins.	CHD1 BCLAF1	2.70e-05	7	40	2	12890497
Pubmed	Proteomic analysis of the cullin 4B interactome using proximity-dependent biotinylation in living cells.	NEFM SREK1 RBMXL1 RBMX	2.91e-05	153	40	4	28225217
Pubmed	WW domains provide a platform for the assembly of multiprotein networks.	CHERP SRSF7 CDK12 BCLAF1	2.98e-05	154	40	4	16055720
Pubmed	Nuclear receptor coactivator 6 mediates the synergistic activation of human cytochrome P-450 2C9 by the constitutive androstane receptor and hepatic nuclear factor-4alpha.	PPARGC1A HNF4A	3.60e-05	8	40	2	18552123
Pubmed	Molecular control of spinal accessory motor neuron/axon development in the mouse spinal cord.	NEFM GLI2	3.60e-05	8	40	2	16267219
Interaction	DHX8 interactions	LENG8 SETD2 CHD1 NKTR GPATCH8 CHERP SRSF7 SPEN RBBP6 CDK12 BCLAF1 RBMX PHRF1 ZRANB2	2.18e-16	292	40	14	int:DHX8
Interaction	DDX23 interactions	NEFM SETD2 CHD1 NKTR SREK1 GPATCH8 CHERP SRSF7 RBBP6 CDK12 BCLAF1 RBMX RSRC1 PHRF1 ZRANB2	8.45e-15	480	40	15	int:DDX23
Interaction	SRSF6 interactions	PPARGC1A SETD2 NKTR SREK1 GPATCH8 CHERP SRSF7 RBMXL1 SPEN RBBP6 CDK12 BCLAF1 SRSF8 RBMX PHRF1	1.68e-14	503	40	15	int:SRSF6
Interaction	SRPK2 interactions	MACF1 SETD2 NKTR SREK1 GPATCH8 CHERP SRSF7 SPEN RBBP6 CDK12 BCLAF1 SRSF8 VAV2 RBMX RSRC1 ZRANB2	1.58e-13	717	40	16	int:SRPK2
Interaction	SRSF4 interactions	PPARGC1A NKTR SREK1 GPATCH8 CHERP SRSF7 RBMXL1 RBBP6 CDK12 SRSF8 SRRM4 RBMX	3.66e-13	300	40	12	int:SRSF4
Interaction	SNRNP40 interactions	LENG8 SETD2 CHD1 NKTR SREK1 GPATCH8 CHERP SRSF7 SPEN RBBP6 CDK12 BCLAF1 RBMX RSRC1 PHRF1	5.16e-13	637	40	15	int:SNRNP40
Interaction	LUC7L interactions	SETD2 NKTR GPATCH8 CHERP SRSF7 RBBP6 BCLAF1 SRSF8 SRRM4 RSRC1 ZRANB2	1.01e-12	242	40	11	int:LUC7L
Interaction	SNRPC interactions	MACF1 SETD2 NKTR SREK1 GPATCH8 SRSF7 RBMXL1 SPEN RBBP6 CDK12 BCLAF1 SRSF8 RBMX	1.51e-12	440	40	13	int:SNRPC
Interaction	RNPS1 interactions	CCNL2 SETD2 NKTR SREK1 GPATCH8 CHERP SRSF7 RBBP6 CDK12 SRRM4 RBMX CCNL1	2.17e-11	425	40	12	int:RNPS1
Interaction	MECP2 interactions	NEFM LENG8 MACF1 SETD2 NKTR SREK1 GPATCH8 CHERP SRSF7 RBMXL1 SPEN RBBP6 CDK12 BCLAF1 SRSF8 RBMX ZRANB2	9.59e-11	1287	40	17	int:MECP2
Interaction	NUP43 interactions	SETD1A SETD2 CHD1 NKTR SREK1 GPATCH8 SRSF7 SPEN RBBP6 CDK12 BCLAF1 RBMX PHRF1	1.21e-10	625	40	13	int:NUP43
Interaction	SNIP1 interactions	NKTR GPATCH8 CHERP SRSF7 PCNX3 RBMXL1 BCLAF1 SRSF8 SRRM4 PHRF1 ZRANB2	3.52e-10	417	40	11	int:SNIP1
Interaction	DHX40 interactions	CCNL2 LENG8 SETD2 CHD1 GPATCH8 CHERP RBBP6 BCLAF1 RBMX	1.14e-09	249	40	9	int:DHX40
Interaction	SNRNP70 interactions	NKTR SREK1 GPATCH8 CHERP SRSF7 RBMXL1 RBBP6 CDK12 BCLAF1 SRSF8 SRRM4 RBMX RSRC1 ZRANB2	2.82e-09	984	40	14	int:SNRNP70
Interaction	CLK2 interactions	SETD2 NKTR GPATCH8 SRSF7 RBMXL1 RBBP6 BCLAF1 SRSF8	3.93e-09	195	40	8	int:CLK2
Interaction	SRSF2 interactions	PPARGC1A SREK1 SRSF7 SPEN CDK12 SRSF8 RBMX CCNL1 ZRANB2	4.32e-09	290	40	9	int:SRSF2
Interaction	SRSF7 interactions	NKTR SREK1 CHERP SRSF7 RBMXL1 SPEN RBBP6 BCLAF1 SRSF8 ZRANB2	7.54e-09	425	40	10	int:SRSF7
Interaction	CLK1 interactions	SRSF7 SPEN RBBP6 CDK12 BCLAF1 SRSF8 SRRM4 RBMX	9.76e-09	219	40	8	int:CLK1
Interaction	CLK3 interactions	GPATCH8 CHERP SRSF7 RBMXL1 RBBP6 BCLAF1 SRSF8 RBMX	1.01e-08	220	40	8	int:CLK3
Interaction	RAD18 interactions	LENG8 SETD1A CHD1 RBMXL1 SPEN RBBP6 CDK12 BCLAF1 SRSF8 ZRANB2	1.50e-08	457	40	10	int:RAD18
Interaction	MAGEB2 interactions	CCNL2 LENG8 NKTR SREK1 CHERP RBBP6 CDK12 SRSF8 ZRANB2	2.15e-08	349	40	9	int:MAGEB2
Interaction	ZC3H18 interactions	LENG8 NKTR SRSF7 RBMXL1 SPEN RBBP6 CDK12 BCLAF1 SRSF8 RBMX RSRC1 ZRANB2	7.75e-08	877	40	12	int:ZC3H18
Interaction	SAP18 interactions	SETD2 NKTR SREK1 GPATCH8 SRSF7 RBBP6 SRSF8 PHRF1	1.27e-07	305	40	8	int:SAP18
Interaction	SRSF11 interactions	SREK1 GPATCH8 SRSF7 RBMXL1 BCLAF1 SRRM4 ZRANB2	1.33e-07	203	40	7	int:SRSF11
Interaction	JMJD6 interactions	CCNL2 SETD2 SREK1 CHERP RSRC1 CCNL1 PHRF1	1.43e-07	205	40	7	int:JMJD6
Interaction	THRAP3 interactions	SREK1 SRSF7 RBBP6 CDK12 BCLAF1 SRSF8 RBMX LRRFIP1 PHRF1	1.65e-07	443	40	9	int:THRAP3
Interaction	CSNK2A1 interactions	CCNL2 SETD1A MACF1 NKTR SREK1 CDK12 BCLAF1 RBMX RSRC1 CCNL1 PHRF1 ZRANB2	1.98e-07	956	40	12	int:CSNK2A1
Interaction	BCLAF1 interactions	CHD1 SRSF7 RBMXL1 SPEN RBBP6 CDK12 BCLAF1 PHRF1	2.16e-07	327	40	8	int:BCLAF1
Interaction	PURG interactions	LENG8 NKTR SREK1 CHERP RBMXL1 RBBP6 CDK12	2.53e-07	223	40	7	int:PURG
Interaction	CSNK2B interactions	CCNL2 LENG8 PIMREG SETD2 NKTR CHERP BCLAF1 RSRC1 CCNL1 PHRF1	2.80e-07	625	40	10	int:CSNK2B
Interaction	LUC7L2 interactions	SREK1 GPATCH8 SRSF7 BCLAF1 SRSF8 SRRM4 LRRFIP1 ZRANB2	3.86e-07	353	40	8	int:LUC7L2
Interaction	SNRPB interactions	MACF1 SETD2 NKTR CHERP SRSF7 RBBP6 BCLAF1 RBMX RSRC1	6.05e-07	517	40	9	int:SNRPB
Interaction	SRSF3 interactions	CHD1 SREK1 SRSF7 RBMXL1 SPEN RBBP6 CDK12 SRSF8 RBMX	6.55e-07	522	40	9	int:SRSF3
Interaction	NFKBIL1 interactions	SETD1A SETD2 GPATCH8 SPEN ZRANB2	1.09e-06	93	40	5	int:NFKBIL1
Interaction	MYCN interactions	NEFM LENG8 SETD2 GPATCH8 CHERP SRSF7 RBMXL1 RBBP6 CDK12 BCLAF1 RBMX RSRC1 ZRANB2	1.36e-06	1373	40	13	int:MYCN
Interaction	SREK1 interactions	SREK1 SRSF7 SRSF8 SRRM4 RBMX ZRANB2	1.53e-06	183	40	6	int:SREK1
Interaction	SMC5 interactions	LENG8 SETD2 CHD1 SREK1 CHERP SRSF7 SPEN RBBP6 CDK12 BCLAF1 RBMX	2.61e-06	1000	40	11	int:SMC5
Interaction	RBM39 interactions	SETD2 NKTR SREK1 GPATCH8 CHERP SRSF7 CDK12 BCLAF1 SRRM4 RBMX RSRC1	3.88e-06	1042	40	11	int:RBM39
Interaction	IFI6 interactions	SREK1 RBMXL1 CDK12 RSRC1	3.92e-06	54	40	4	int:IFI6
Interaction	SNRPA interactions	LENG8 SETD2 NKTR RBBP6 BCLAF1 SRSF8 RBMX RSRC1	3.96e-06	482	40	8	int:SNRPA
Interaction	PIP4K2A interactions	LENG8 SETD2 GPATCH8 SPEN SRSF8 ZRANB2	4.00e-06	216	40	6	int:PIP4K2A
Interaction	U2AF2 interactions	NKTR GPATCH8 CHERP SRSF7 BCLAF1 SRSF8 RBMX LRRFIP1 ZRANB2	4.04e-06	651	40	9	int:U2AF2
Interaction	KIF20A interactions	NEFM MACF1 CHD1 CHERP SRSF7 RBMXL1 RBBP6 BCLAF1 SRSF8 RBMX ZRANB2	4.25e-06	1052	40	11	int:KIF20A
Interaction	ARRDC3 interactions	GPATCH8 CHERP SRSF7 SPEN RBBP6 BCLAF1	4.94e-06	224	40	6	int:ARRDC3
Interaction	FOLR1 interactions	SREK1 SRSF7 RBBP6 SRSF8 RBMX RSRC1	5.33e-06	227	40	6	int:FOLR1
Interaction	TLE3 interactions	SETD2 GPATCH8 CHERP SPEN RBBP6 CDK12 GLI2	8.16e-06	376	40	7	int:TLE3
Interaction	IFI27L1 interactions	SREK1 RBMXL1 CDK12 RSRC1	8.25e-06	65	40	4	int:IFI27L1
Interaction	TERF2IP interactions	SETD1A SETD2 CHD1 SREK1 SPEN RBBP6 CDK12 ZRANB2	1.07e-05	552	40	8	int:TERF2IP
Interaction	CIT interactions	NEFM MACF1 CHD1 NKTR SREK1 CHERP SRSF7 RBMXL1 RBBP6 BCLAF1 SRSF8 RBMX	1.54e-05	1450	40	12	int:CIT
Interaction	PRPF38A interactions	CHERP SRSF7 SRSF8 SRRM4 CCNL1	1.61e-05	161	40	5	int:PRPF38A
Interaction	ZRSR2 interactions	NKTR CHERP SRRM4 CCNL1	1.62e-05	77	40	4	int:ZRSR2
Interaction	MEN1 interactions	LENG8 SETD1A CHD1 SREK1 CHERP SRSF7 SPEN RBBP6 BCLAF1 RBMX	2.40e-05	1029	40	10	int:MEN1
Interaction	SPEN interactions	SRSF7 HNF4A SPEN CDK12 BCLAF1	2.60e-05	178	40	5	int:SPEN
Interaction	CDK11B interactions	CCNL2 GPATCH8 BCLAF1 CCNL1 ZRANB2	2.97e-05	183	40	5	int:CDK11B
Interaction	CUL7 interactions	MACF1 SETD2 CHD1 SRSF7 SPEN BCLAF1 RBMX PHRF1 ZRANB2	3.25e-05	845	40	9	int:CUL7
Interaction	CBX3 interactions	SETD1A MACF1 SETD2 CHD1 SPEN RBBP6 CDK12 ZRANB2	3.31e-05	646	40	8	int:CBX3
Interaction	LINC02910 interactions	SREK1 RBMXL1 CDK12 RSRC1	3.72e-05	95	40	4	int:LINC02910
Interaction	SRPK1 interactions	SREK1 CHERP SRSF7 BCLAF1 SRSF8 RSRC1 ZRANB2	3.77e-05	477	40	7	int:SRPK1
Interaction	BMI1 interactions	LENG8 GPATCH8 CHERP SRSF7 HNF4A SPEN BCLAF1 RSRC1	3.82e-05	659	40	8	int:BMI1
Interaction	LUZP4 interactions	SRSF7 BCLAF1 SRRM4 RBMX	4.37e-05	99	40	4	int:LUZP4
Interaction	SRRM4 interactions	SREK1 SRRM4 RSRC1	5.37e-05	37	40	3	int:SRRM4
Interaction	OBSL1 interactions	MACF1 CHD1 CHERP SRSF7 SPEN BCLAF1 RBMX PLEKHA3 ZRANB2	5.41e-05	902	40	9	int:OBSL1
Interaction	EWSR1 interactions	PPARGC1A GPATCH8 CHERP SRSF7 RBBP6 CDK12 RBMX PHRF1 ZRANB2	5.60e-05	906	40	9	int:EWSR1
Interaction	NR2C2 interactions	SETD1A CHD1 NKTR SREK1 CHERP SRSF7 HNF4A RBBP6 SRSF8 RBMX RSRC1	6.30e-05	1403	40	11	int:NR2C2
Interaction	CPSF6 interactions	LENG8 SETD2 NKTR SRSF7 RBBP6 BCLAF1 RBMX	7.00e-05	526	40	7	int:CPSF6
Interaction	CHD4 interactions	SETD1A GPATCH8 CHERP SRSF7 SPEN RBBP6 BCLAF1 RBMX LRRFIP1	7.32e-05	938	40	9	int:CHD4
Interaction	CAMKV interactions	GPATCH8 SPEN BCLAF1 ZRANB2	8.67e-05	118	40	4	int:CAMKV
Interaction	DCAF4 interactions	SETD1A SETD2 CHD1 SRSF7 SPEN RBBP6	9.37e-05	378	40	6	int:DCAF4
Interaction	TRA2B interactions	SETD1A SREK1 SRSF7 SRSF8 RBMX ZRANB2	1.04e-04	385	40	6	int:TRA2B
Interaction	BTBD8 interactions	LENG8 MACF1 BCLAF1	1.04e-04	46	40	3	int:BTBD8
Interaction	LARP4B interactions	CHERP RBMXL1 RBBP6 BCLAF1 SRSF8	1.08e-04	240	40	5	int:LARP4B
Interaction	SRSF1 interactions	SREK1 CHERP SRSF7 RBMXL1 CDK12 RBMX RSRC1	1.16e-04	570	40	7	int:SRSF1
Interaction	BTRC interactions	CHD1 GPATCH8 SRSF7 BCLAF1 GLI2 SRSF8 RBMX ZRANB2	1.19e-04	775	40	8	int:BTRC
Interaction	CWC15 interactions	SRSF7 SPEN CDK12 RBMX	1.42e-04	134	40	4	int:CWC15
Interaction	PAIP2B interactions	SREK1 RBMXL1 BCLAF1	1.50e-04	52	40	3	int:PAIP2B
Interaction	KIF23 interactions	MACF1 CHD1 CHERP SRSF7 RBMXL1 BCLAF1 SRSF8 RBMX ZRANB2	1.51e-04	1031	40	9	int:KIF23
Interaction	UQCR11 interactions	RBMXL1 CDK12 RSRC1	1.58e-04	53	40	3	int:UQCR11
Interaction	ATXN1 interactions	SETD2 GPATCH8 SRSF7 HNF4A SPEN RBBP6 BCLAF1 RSRC1 ZRANB2	1.60e-04	1039	40	9	int:ATXN1
Interaction	SAA1 interactions	RBMXL1 CDK12 RSRC1	1.67e-04	54	40	3	int:SAA1
Interaction	PABPC5 interactions	CHERP RBMXL1 RBBP6 SRSF8	1.77e-04	142	40	4	int:PABPC5
Interaction	TFIP11 interactions	SRSF7 SPEN RBBP6 RBMX RSRC1 CCNL1	1.82e-04	427	40	6	int:TFIP11
Interaction	SIRT6 interactions	LENG8 SETD1A SETD2 NKTR GPATCH8 EIF2AK3 BCLAF1	2.10e-04	628	40	7	int:SIRT6
Interaction	HNRNPC interactions	SREK1 SRSF7 RBMXL1 RBBP6 BCLAF1 SRSF8 RBMX	2.23e-04	634	40	7	int:HNRNPC
Interaction	PRPF40A interactions	SREK1 CHERP SRSF7 SPEN CDK12 CCNL1	2.30e-04	446	40	6	int:PRPF40A
Interaction	YAP1 interactions	NEFM SETD1A SETD2 CHD1 SRSF7 SPEN RBBP6 CDK12 BCLAF1	2.37e-04	1095	40	9	int:YAP1
Interaction	SUZ12 interactions	SETD1A CHD1 SRSF7 HNF4A EIF2AK3 BCLAF1 SRSF8	2.45e-04	644	40	7	int:SUZ12
Interaction	RBMXL1 interactions	SRSF7 RBMXL1 BCLAF1 RBMX	2.48e-04	155	40	4	int:RBMXL1
Interaction	HTATSF1 interactions	SRSF7 SPEN BCLAF1 ZRANB2	2.60e-04	157	40	4	int:HTATSF1
Interaction	SRRM2 interactions	SRSF7 SPEN RBBP6 CDK12 RBMX ZRANB2	2.78e-04	462	40	6	int:SRRM2
Interaction	NKAPD1 interactions	NKTR BCLAF1 SRSF8 CCNL1	2.87e-04	161	40	4	int:NKAPD1
Interaction	ECT2 interactions	MACF1 SREK1 CHERP SRSF7 RBMXL1 BCLAF1 SRSF8 RBMX	2.99e-04	887	40	8	int:ECT2
Interaction	SNRPA1 interactions	SREK1 GPATCH8 CHERP SRSF7 RBMX	3.04e-04	300	40	5	int:SNRPA1
Interaction	SF3A1 interactions	SETD2 CHERP SRSF7 RBBP6 BCLAF1 RBMX	3.09e-04	471	40	6	int:SF3A1
Interaction	PNN interactions	NKTR SREK1 SRSF7 RBBP6 BCLAF1	3.13e-04	302	40	5	int:PNN
Interaction	SRSF5 interactions	PPARGC1A SREK1 CHERP SRSF7 CDK12 SRSF8	3.19e-04	474	40	6	int:SRSF5
Interaction	RC3H1 interactions	SREK1 CHERP SRSF7 CDK12 BCLAF1 RBMX ZRANB2	3.32e-04	677	40	7	int:RC3H1
Interaction	RPL31 interactions	LENG8 MACF1 SREK1 CHERP BCLAF1 RBMX ZRANB2	3.41e-04	680	40	7	int:RPL31
Interaction	SSRP1 interactions	SETD2 CHD1 SREK1 RBBP6 BCLAF1 RBMX RSRC1	3.56e-04	685	40	7	int:SSRP1
Interaction	HMGB1 interactions	NKTR SRSF7 BCLAF1 RBMX CCNL1 ZRANB2	3.65e-04	486	40	6	int:HMGB1
Interaction	RNF113A interactions	CHD1 SREK1 CHERP SRSF7 RBBP6 BCLAF1 ZRANB2	3.79e-04	692	40	7	int:RNF113A
GeneFamily	RNA binding motif containing	PPARGC1A SETD1A SREK1 SRSF7 RBMXL1 SPEN RBMX	2.74e-08	213	28	7	725
GeneFamily	RNA binding motif containing\|Serine and arginine rich splicing factors	SRSF7 SRSF8	1.51e-04	12	28	2	737
GeneFamily	G-patch domain containing\|Minor histocompatibility antigens	GPATCH8 CHERP	5.24e-04	22	28	2	579
GeneFamily	Cyclins	CCNL2 CCNL1	8.53e-04	28	28	2	473
GeneFamily	Zinc fingers C2H2-type\|Lysine methyltransferases\|PR/SET domain family	SETD1A SETD2	1.26e-03	34	28	2	487
Coexpression	NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_3DY_DN	CCNL2 LENG8 NKTR SREK1 RBBP6 EIF2AK3 CDK12 BCLAF1 CCNL1	1.44e-08	432	40	9	M41149
Coexpression	GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_NFATC1_KO_8H_UP	CCNL2 SETD2 CHD1 GPATCH8 SPEN CDK12	4.46e-07	192	40	6	M8272
Coexpression	NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_7DY_NEGATIVE	CHD1 NKTR CHERP SRSF7 RBBP6 BCLAF1 LRRFIP1 CCNL1	4.99e-07	474	40	8	M40991
Coexpression	GSE25146_UNSTIM_VS_HELIOBACTER_PYLORI_LPS_STIM_AGS_CELL_DN	CCNL2 NKTR SRSF7 BCLAF1 CCNL1	5.28e-06	166	40	5	M8129
Coexpression	NAKAYA_PBMC_FLUMIST_AGE_18_50YO_3DY_DN	CHD1 SREK1 RBBP6 EIF2AK3 CDK12 BCLAF1 LRRFIP1 CCNL1	7.27e-06	680	40	8	M41089
Coexpression	JISON_SICKLE_CELL_DISEASE_DN	SETD2 GPATCH8 RBBP6 BCLAF1 SRSF8	9.17e-06	186	40	5	M4911
Coexpression	HOEBEKE_LYMPHOID_STEM_CELL_UP	MACF1 RBBP6 LRRFIP1 CCNL1	1.45e-05	97	40	4	M14698
Coexpression	FAN_OVARY_CL7_ANGEIOGENIC_ENDOTHELIAL_CELL	NKTR SRSF7 BCLAF1 LRRFIP1 CCNL1	3.87e-05	251	40	5	M41709
Coexpression	BUSSLINGER_GASTRIC_IMMUNE_CELLS	MACF1 SETD2 CHD1 GPATCH8 SRSF7 SPEN RBBP6 BCLAF1 LRRFIP1 CCNL1	6.10e-05	1492	40	10	M40023
Coexpression	GSE21033_1H_VS_12H_POLYIC_STIM_DC_DN	SETD2 NKTR RBBP6 ZRANB2	6.31e-05	141	40	4	M7720
Coexpression	BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_D	NEFM NKTR SPEN PLEKHA3 ZRANB2	6.39e-05	279	40	5	M2246
Coexpression	BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_D	NEFM NKTR SPEN PLEKHA3 ZRANB2	8.06e-05	293	40	5	MM895
Coexpression	SCHERER_PBMC_APSV_WETVAX_AGE_18_32YO_50_TO_60DY_UP	SETD2 CHD1 RBBP6 CCNL1	1.27e-04	169	40	4	M40877
Coexpression	LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_DN	CCNL2 MACF1 SETD2 NKTR SPEN SRSF8 ZRANB2	1.96e-04	807	40	7	M14594
Coexpression	NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_3DY_NEGATIVE	SETD2 CHD1 NKTR CDK12 BCLAF1	2.19e-04	363	40	5	M41103
Coexpression	GSE29617_CTRL_VS_DAY3_TIV_FLU_VACCINE_PBMC_2008_UP	SREK1 EIF2AK3 BCLAF1 CCNL1	2.24e-04	196	40	4	M4928
Coexpression	GSE12845_IGD_NEG_BLOOD_VS_NAIVE_TONSIL_BCELL_DN	MACF1 NKTR RSRC1 CCNL1	2.29e-04	197	40	4	M3193
Coexpression	GSE21927_SPLENIC_VS_TUMOR_MONOCYTES_FROM_C26GM_TUMOROUS_MICE_BALBC_DN	CCNL2 MACF1 SETD2 NKTR	2.33e-04	198	40	4	M7605
Coexpression	GSE36476_CTRL_VS_TSST_ACT_72H_MEMORY_CD4_TCELL_YOUNG_UP	SETD2 CHD1 NKTR CCNL1	2.33e-04	198	40	4	M5293
Coexpression	GSE29618_PRE_VS_DAY7_FLU_VACCINE_MONOCYTE_DN	CHERP SRSF7 REPS2 CCNL1	2.38e-04	199	40	4	M4977
Coexpression	GSE21927_C26GM_VS_4T1_TUMOR_MONOCYTE_BALBC_DN	CCNL2 MACF1 NKTR CCNL1	2.38e-04	199	40	4	M7607
Coexpression	GSE6674_ANTI_IGM_VS_PL2_3_STIM_BCELL_DN	CHD1 RBMXL1 PLEKHA3 ZRANB2	2.38e-04	199	40	4	M6932
Coexpression	GSE17721_CTRL_VS_LPS_4H_BMDC_DN	CHD1 GOSR1 PLEKHA3 CCNL1	2.42e-04	200	40	4	M3690
Coexpression	GSE5503_LIVER_DC_VS_MLN_DC_ACTIVATED_ALLOGENIC_TCELL_DN	GPATCH8 EIF2AK3 BCLAF1 GOSR1	2.42e-04	200	40	4	M6991
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	MACF1 SETD2 CHD1 GPATCH8 SRSF7 SPEN LRRFIP1	2.81e-04	856	40	7	M4500
Coexpression	DE_YY1_TARGETS_DN	MACF1 RBBP6 CCNL1	3.88e-04	93	40	3	M3278
Coexpression	BENPORATH_CYCLING_GENES	LENG8 PIMREG NKTR SRSF7 BCLAF1 ZRANB2	4.19e-04	648	40	6	M8156
Coexpression	ZHENG_CORD_BLOOD_C7_PUTATIVE_LYMPHOID_PRIMED_MULTIPOTENT_PROGENITOR_1	CHD1 LRRFIP1 ZRANB2	4.26e-04	96	40	3	M39216
Coexpression	HAMAI_APOPTOSIS_VIA_TRAIL_UP	PPARGC1A CHD1 NKTR SREK1 BCLAF1 CCNL1	4.47e-04	656	40	6	M18979
Coexpression	LAKE_ADULT_KIDNEY_C17_COLLECTING_SYSTEM_PCS_STRESSED_DISSOC_SUBSET	PPARGC1A EIF2AK3 LRRFIP1 CCNL1	4.84e-04	240	40	4	M39236
Coexpression	MILI_PSEUDOPODIA_HAPTOTAXIS_DN	LENG8 SETD1A PIMREG PCNX3 EIF2AK3 PHRF1	5.44e-04	681	40	6	M5314
Coexpression	MITSIADES_RESPONSE_TO_APLIDIN_DN	MACF1 SPEN RBBP6 RSRC1	5.64e-04	250	40	4	M11318
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5	NEFM PPARGC1A SETD2 CHD1 NKTR CACNG4 RBBP6 EIF2AK3 GLI2 GOSR1	2.33e-06	831	40	10	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500_k-means-cluster#5	NEFM PPARGC1A CHD1 CACNG4 BCLAF1	7.18e-05	232	40	5	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500_K5
CoexpressionAtlas	FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1	WDR27 MACF1 SETD2 NKTR RBBP6 EIF2AK3 GLI2 GOSR1	8.66e-05	780	40	8	Facebase_RNAseq_e10.5_Lateral Nasal Eminence_2500_K1
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_F-vs-M_top280_280	PPARGC1A CHD1 CHERP GLI2 RSRC1	1.23e-04	260	40	5	gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_250_F-vs-M
ToppCell	10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8\|GI_small-bowel / Manually curated celltypes from each tissue	MACF1 CHD1 NKTR SREK1 SPEN EIF2AK3 BCLAF1 CCNL1	5.49e-12	188	40	8	ab9b725d6e0cdab8e9ddda6dee09e14730e9a578
ToppCell	mild\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	MACF1 SETD2 CHD1 NKTR SREK1 BCLAF1 CCNL1 ZRANB2	9.02e-12	200	40	8	12f1685ce8f218433068e090c9d839cd5a1910bf
ToppCell	COVID-19\|World / Disease, condition lineage and cell class	MACF1 SETD2 CHD1 SREK1 RBBP6 BCLAF1 CCNL1	5.08e-10	200	40	7	7dec470c379cd89f05a0f37c8628b21f136e52f0
ToppCell	3'_v3-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8\|GI_small-bowel / Manually curated celltypes from each tissue	MACF1 NKTR SREK1 SRSF7 CCNL1 ZRANB2	3.84e-09	147	40	6	94998bc40f5c08295cfe3bdcbe43f13b1e564b3d
ToppCell	COVID-19-COVID-19_Mild\|COVID-19 / Disease, condition lineage and cell class	LENG8 CHD1 NKTR SRSF7 BCLAF1 CCNL1	2.42e-08	200	40	6	62c25042086f1afd1102e0720e933c2e476468fd
ToppCell	3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8\|lymph-node_spleen / Manually curated celltypes from each tissue	MACF1 CHD1 NKTR SRSF7 CCNL1	4.42e-07	171	40	5	2e9a20f8980b78325c52065a9c14ab3656267c05
ToppCell	droplet-Marrow-nan-3m\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MACF1 SETD2 CHD1 BCLAF1 CCNL1	6.35e-07	184	40	5	1154a5ad7b8512272b7476f949ddac350910bfb7
ToppCell	droplet-Bladder-nan\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CHD1 SRSF7 CDK12 LRRFIP1 CCNL1	6.87e-07	187	40	5	663991a8afe652e92363b64bcbd68c14d0307f0e
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25\|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k)	SETD2 CHD1 NKTR BCLAF1 CCNL1	7.63e-07	191	40	5	1ecd9849d14d5ebf3daf610e83fb50820cafd3ed
ToppCell	10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8\|lymph-node_spleen / Manually curated celltypes from each tissue	MACF1 CHD1 NKTR SREK1 CCNL1	7.83e-07	192	40	5	47646d7e4990be85072987f92bf18d52f8da752e
ToppCell	H1299-infected-SARSCoV2\|infected / Cell line, Condition and Strain	CCNL2 NKTR SREK1 RBBP6 CCNL1	8.89e-07	197	40	5	0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e
ToppCell	COVID-19_Mild-Classical_Monocyte-cMono_4\|Classical_Monocyte / Disease condition and Cell class	LENG8 CHD1 NKTR SREK1 BCLAF1	8.89e-07	197	40	5	e666f6580e9a20b5e550f02125706db17eec8510
ToppCell	COVID-19_Mild\|World / Disease group, lineage and cell class	CHD1 NKTR SREK1 BCLAF1 CCNL1	8.89e-07	197	40	5	5c33454b10023decd2f5ccda9229b6512659711e
ToppCell	severe-low-quality_cells\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	MACF1 NKTR SREK1 CCNL1 ZRANB2	8.89e-07	197	40	5	57ebd552f10d6278623b52a3d484d4b91ae1d028
ToppCell	moderate-Lymphoid-CTL\|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	MACF1 NKTR SRSF7 CCNL1 ZRANB2	9.11e-07	198	40	5	0a868098b1ee4b28b2149ed766acb09e9c0ce14c
ToppCell	PBMC-Mild\|PBMC / Location, Disease Group, Cell group, Cell class (2021.03.09)	CHD1 NKTR SREK1 BCLAF1 CCNL1	9.11e-07	198	40	5	44417089b62056269cac38d3134ff209c05b7007
ToppCell	PBMC-Mild\|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	CHD1 NKTR SREK1 BCLAF1 CCNL1	9.11e-07	198	40	5	28ef3fc4c17dcb765537b75917f7db78baa522db
ToppCell	mild-low-quality_cells\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	MACF1 NKTR SREK1 CCNL1 ZRANB2	9.34e-07	199	40	5	f0b0097df0026496470a80d8cc9375ffd8389b00
ToppCell	3'_v3-blood-Lymphocytic_T_CD4-T_CD4/CD8\|blood / Manually curated celltypes from each tissue	MACF1 NKTR SRSF7 CCNL1	6.51e-06	135	40	4	ae2d3a42e567b5bade304c0caa497eb725be3565
ToppCell	ILEUM-non-inflamed-(3)_MNP-(3)_moDC\|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	MACF1 NKTR SREK1 SRSF7	6.51e-06	135	40	4	b7a792a7c0c22d8b703509f134115f0e394d7de0
ToppCell	10x5'-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8\|bone_marrow / Manually curated celltypes from each tissue	MACF1 CHD1 NKTR CCNL1	1.15e-05	156	40	4	1545169694f686d28648a68b552c2ae606599d66
ToppCell	10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8\|Liver / Manually curated celltypes from each tissue	MACF1 NKTR SRSF7 CCNL1	2.07e-05	181	40	4	f2315414e714ac86211546a935660c4be6e85f1b
ToppCell	Calu_3-infected\|Calu_3 / Cell line, Condition and Strain	SETD2 RBBP6 CDK12 CCNL1	2.16e-05	183	40	4	8f7f5000645f24f20a8d7700c4df1f8953a1780b
ToppCell	ILEUM-inflamed-(3)_MNP-(3)_moDC\|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	CHD1 NKTR SREK1 SRSF7	2.35e-05	187	40	4	0099def970fbc828756fbf853eca2ce77b8cd342
ToppCell	droplet-Tongue-nan\|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CHD1 CDK12 LRRFIP1 CCNL1	2.40e-05	188	40	4	d62cc37e86b7b186e53aeb7f421c4e5ee28f23bd
ToppCell	renal_cortex_nuclei-Adult_normal_reference\|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group	LENG8 NKTR REPS2 ZRANB2	2.45e-05	189	40	4	a48df46274d51e84ffb40264646de7346104efb9
ToppCell	droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-nan\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CHD1 NKTR BCLAF1 CCNL1	2.55e-05	191	40	4	7d1595e616f6f111fc2f5bc1b179c5d67d624cc9
ToppCell	PBMC-Control-cDC_6\|Control / Compartment, Disease Groups and Clusters	CHD1 SRSF7 BCLAF1 CCNL1	2.60e-05	192	40	4	41a7201febb7d88a39e4ee64df04cce18c691df8
ToppCell	H1299-infected\|H1299 / Cell line, Condition and Strain	CCNL2 NKTR SREK1 CCNL1	2.60e-05	192	40	4	9cf8049bdc3e0f81ce69042beac72b08d8f38b4e
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	BEST3 PPARGC1A CACNG4 VAV2	2.66e-05	193	40	4	4979862c0c16e6b4baa4c79894f1d237c861f5a5
ToppCell	droplet-Limb_Muscle-MUSCLE\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MACF1 CHD1 CDK12 BCLAF1	2.71e-05	194	40	4	e3d63874111d1e8da3977329426e4dcf68d6de87
ToppCell	droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CHD1 NKTR BCLAF1 CCNL1	2.77e-05	195	40	4	5c86fddd6d0530beecf45ea5ba6b823123847696
ToppCell	COVID-19_Mild-Classical_Monocyte-cMono_4\|COVID-19_Mild / Disease condition and Cell class	LENG8 CHD1 SREK1 LRRFIP1	2.82e-05	196	40	4	3729d1444c65cad640377894decc64129bc3fd5b
ToppCell	moderate-Lymphoid-Treg\|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	MACF1 NKTR CCNL1 ZRANB2	2.82e-05	196	40	4	9152f4a8a27ff4ee28f231c5ad00eb2edd9ea6da
ToppCell	(11)_FOXN4+-(2)_GFP_FOXI1\|(11)_FOXN4+ / shred by cell type by condition	CHD1 RBBP6 BCLAF1 LRRFIP1	2.94e-05	198	40	4	76d40b8c2f8399725b3a62ee2ae0896559cf91eb
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-6m-Neuronal-Intermediate\|6m / Sample Type, Dataset, Time_group, and Cell type.	SPEN RBBP6 BCLAF1 CCNL1	3.05e-05	200	40	4	7c261e39ac30b318511373ab7302aa53b8b81b9c
ToppCell	3'_v3-Lung-Lymphocytic_T_CD4-T_CD4/CD8\|Lung / Manually curated celltypes from each tissue	MACF1 NKTR SRSF7	3.34e-04	151	40	3	999c11d19b61d6b130ad5e623afa83cbdfe13cdd
ToppCell	Ionocyte\|World / shred by cell class for nasal brushing	BEST3 PPARGC1A SRRM4	3.54e-04	154	40	3	6b78fb0c96fc7b5e901c39b3424f4aa8d0a6b9cf
ToppCell	3'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	NEFM PPARGC1A SETD1A	3.96e-04	160	40	3	a76ad44b5f25f59d6b9333fb45f8bb96196a3090
ToppCell	3'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	NEFM PPARGC1A SETD1A	3.96e-04	160	40	3	af84da18c85037f49f55e8958f00f12140226982
ToppCell	3'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	NEFM PPARGC1A SETD1A	3.96e-04	160	40	3	f7ca98beaa24f9674d503588eb15d341c4135d77
ToppCell	Children_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	NEFM BEST3 SRRM4	4.25e-04	164	40	3	be49af6335f2505065cde2cb9800e4a5516811b1
ToppCell	LPS-antiTNF-Endothelial-Mes-Like-Gen_Cap\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PPARGC1A SREK1 SRSF8	4.41e-04	166	40	3	3b750d4023a0a09d86113aae5a97d84391f7b482
ToppCell	Children_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)\|Children_(3_yrs) / Lineage, Cell type, age group and donor	NEFM BEST3 SRRM4	4.64e-04	169	40	3	b6b5bb6408c1305a00719e1b88a5e1202081faf3
ToppCell	BL-critical-LOC-Epithelial-Ionocyte\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	BEST3 PPARGC1A SRRM4	4.72e-04	170	40	3	b465df2dac6b4e98b4ede6ad0c6347656757885c
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Vip\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	CACNG4 VAV2 SRRM4	4.89e-04	172	40	3	7e1a7700a4c2b1d100da1d6e475e73498ebb605a
ToppCell	NS-critical-d_16-33-Epithelial-unknown_epithelial\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	NEFM GPATCH8 SRSF7	4.89e-04	172	40	3	c0b5e4889aef2f168d9f6db19a63b24bfd249316
ToppCell	critical-Epithelial-unknown_epithelial\|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	NEFM SRSF7 CCNL1	4.97e-04	173	40	3	4144b1cdefa8c37b6ac7a6d249fa5292ffb2b8b2
ToppCell	BAL-Mild-Epithelial-Epithelial-AT1/AT2\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	BEST3 PPARGC1A SRRM4	5.06e-04	174	40	3	b7f5492ce8098f7eb0aef30ee558d00738d59d0e
ToppCell	3'-GW_trimst-1.5-LargeIntestine-Neuronal-neurons_B-Branch_B1_(eMN)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SETD2 CACNG4 SRRM4	5.06e-04	174	40	3	271c51d220842402975d97c86c9acfdbdf62a32c
ToppCell	BAL-Mild-Epithelial-Epithelial-AT1/AT2-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	BEST3 PPARGC1A SRRM4	5.06e-04	174	40	3	cafe4d6b5f08d8888e9db6e196c66df991c03e7b
ToppCell	BAL-Mild-Epithelial-Epithelial-AT1/AT2-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	BEST3 PPARGC1A SRRM4	5.06e-04	174	40	3	71730503be3d9c839c4c9e950145e2101d682a1c
ToppCell	BAL-Mild-Epithelial-Epithelial-AT1/AT2\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	BEST3 PPARGC1A SRRM4	5.06e-04	174	40	3	ee8ac51fa0b426ad7b7453371bb79c8bf8c1d358
ToppCell	3'_v3\|World / Manually curated celltypes from each tissue	NKTR LRRFIP1 CCNL1	5.40e-04	178	40	3	42502f14d9c756df8104900ac6484477b885d3d9
ToppCell	droplet-Limb_Muscle-MUSCLE-30m\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CHD1 CDK12 BCLAF1	5.40e-04	178	40	3	01dafd19de04eff459253eaa9a35debf8f3deedf
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	LENG8 MACF1 NKTR	5.49e-04	179	40	3	6e965e424eebef50f0202cff75f458be395cfca1
ToppCell	15-Distal-Epithelial-Neuroendocrine\|Distal / Age, Tissue, Lineage and Cell class	BEST3 HNF4A SRRM4	5.49e-04	179	40	3	bc04789f0fbd293fdcea66acba8cf227af251b7a
ToppCell	Hippocampus-Macroglia-POLYDENDROCYTE-P5\|Hippocampus / BrainAtlas - Mouse McCarroll V32	PIMREG SRSF7 RBMX	5.58e-04	180	40	3	44988c34861df359a68376500c42a64fbcc4b431
ToppCell	3'-GW_trimst-1-LargeIntestine-Neuronal-neurons_B-Branch_B2_(eMN)\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	NEFM SRRM5 SRRM4	5.58e-04	180	40	3	368ff7fcfd21ad248f96a83a8b191040ba7d8670
ToppCell	droplet-Spleen-nan-18m\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MACF1 CHD1 CCNL1	5.76e-04	182	40	3	eeb5dfa4539e9ca5220f26bc2b65717ddcf13b6c
ToppCell	droplet-Marrow-nan-3m-Myeloid-nan\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MACF1 CHD1 CCNL1	5.76e-04	182	40	3	f8c73baaaca145e2efc48f10f636feb79c8fc779
ToppCell	wk_15-18-Epithelial-Proximal_epithelial-GHRL+_neuroendocrine\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	CACNG4 HNF4A SRRM4	5.85e-04	183	40	3	8820cfed27b292bc0bc9cde4005219ed41900552
ToppCell	droplet-Spleen-nan-18m-Lymphocytic\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MACF1 CHD1 CCNL1	5.85e-04	183	40	3	28cbf909424f3be4491d49832f0aca0386560814
ToppCell	droplet-Spleen-nan-18m-Lymphocytic-nan\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MACF1 CHD1 CCNL1	5.85e-04	183	40	3	3fa608aa6b119869ec3280dc388dfee57160e63a
ToppCell	3'-Broncho-tracheal-Epithelial-Neuro-endocrine/ionocytic-ionocyte-Ionocyte-Ionocyte_L.0.7.0.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	BEST3 PPARGC1A SRRM4	5.95e-04	184	40	3	a60802e11dcc5f932811260b08a95a32f60f6b19
ToppCell	ILEUM-inflamed-(1)_T_cell-(1)_CD8_Trm\|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	NKTR SRSF7 BCLAF1	5.95e-04	184	40	3	cef3ee2a4a0af961aa3b4c92150d423e841ae8c1
ToppCell	3'-Broncho-tracheal-Epithelial-Neuro-endocrine/ionocytic-ionocyte-Ionocyte\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	BEST3 PPARGC1A SRRM4	5.95e-04	184	40	3	2a2fb691cc9414ef5b06c26239d2da03d6d7e5c2
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-5_PVALB_TRIM67\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	BEST3 PPARGC1A CACNG4	5.95e-04	184	40	3	7f6c8912677764d438ab0555faca344d74c2f483
ToppCell	3'-Broncho-tracheal-Epithelial-Neuro-endocrine/ionocytic-ionocyte\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	BEST3 PPARGC1A SRRM4	5.95e-04	184	40	3	39c230d32e4259bc784e0edfd9e2884c96898564
ToppCell	droplet-Marrow-nan-3m-Myeloid\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MACF1 CHD1 CCNL1	6.04e-04	185	40	3	7adfa929930cfa795cbfbd9f1a0b439e08aa765d
ToppCell	saliva-Severe-critical_progression_d28-40\|saliva / Compartment, severity and other cell annotations on 10x 3' data (130k)	CHD1 BCLAF1 CCNL1	6.14e-04	186	40	3	0095560ca776b01aa473ad4d6015ed78fc93ff51
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	BEST3 PPARGC1A VAV2	6.23e-04	187	40	3	d413fb4b1531b297af5012a392b88128510c2de8
ToppCell	LV-14._Fibroblast_III\|World / Chamber and Cluster_Paper	CHD1 EIF2AK3 CCNL1	6.43e-04	189	40	3	3922135d1f6fc768d71ba3b465585fead6ea68a8
ToppCell	ILEUM-non-inflamed-(1)_T_cell-(1)_CD8_Trm\|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	NKTR SRSF7 BCLAF1	6.43e-04	189	40	3	2c8a2fb76ea002bac554bc1c761ce960b5e116e1
ToppCell	ILEUM-inflamed-(5)_Plasma-(5)_IgA_plasma_cells\|(5)_Plasma / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	NKTR SRSF7 BCLAF1	6.43e-04	189	40	3	a0634d72bfdd5f93877724ed6480b50a3a046f71
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	BEST3 PPARGC1A VAV2	6.53e-04	190	40	3	26843ec1d19ac85a50990705353b802745d33e4d
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	BEST3 PPARGC1A VAV2	6.53e-04	190	40	3	305fbef734c350cfbf786ca7ff6e07093aab56ea
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	BEST3 PPARGC1A VAV2	6.53e-04	190	40	3	e58e4b6fbeb4368f738adac67ec10879c0966f0f
ToppCell	PSB-critical-LOC-Epithelial-Ionocyte\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	BEST3 PPARGC1A SRRM4	6.63e-04	191	40	3	8f4637e801554e2343b974fe7794f01dd2151418
ToppCell	CD8+_Memory_T_cell-CV-7\|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster	MACF1 NKTR SPEN	6.63e-04	191	40	3	9454f642c3621370fa23640b631301346b300950
ToppCell	368C-Lymphocytic-NK_cells-NK_cell_D3\|NK_cells / Donor, Lineage, Cell class and subclass (all cells)	LENG8 GOSR1 RSRC1	6.63e-04	191	40	3	d7920f4a602b50d0ef064eb47001e71939695ed2
ToppCell	ILEUM-non-inflamed-(1)_CD8_Trm\|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	NKTR SRSF7 BCLAF1	6.73e-04	192	40	3	a9f89043c97cd2b0ba165e69ee5681094410af37
ToppCell	control-Lymphoid-CTL\|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	BCLAF1 RSRC1 ZRANB2	6.83e-04	193	40	3	89d407a88b5956559a589425b89b3eb8dc78e1dd
ToppCell	severe-low-quality_cells\|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	MACF1 NKTR ZRANB2	6.83e-04	193	40	3	9337bc93e3904c7fc7c93c328518bcd6453b1e8c
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	MACF1 GLI2 VAV2	6.83e-04	193	40	3	b3ad5ff480d99217f36cc7471e5a96a519ddb409
ToppCell	10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-T_lymphocytic-CD8-positive,_alpha-beta_T_cell\|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	MACF1 NKTR SRSF7	6.83e-04	193	40	3	a594f89a18273797506287d9e22f72abe53e4920
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	BEST3 PPARGC1A VAV2	6.83e-04	193	40	3	c4b22b62f3cc7bf0ec0eba76e1504c236290bbc9
ToppCell	COVID-19_Convalescent-PLT_4\|COVID-19_Convalescent / Disease Group and Platelet Clusters	SREK1 SRSF7 CCNL1	6.93e-04	194	40	3	ce1fad4e76a87f0c35e430ed1f2262395df882fd
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_anti-infl-G\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	LENG8 SRSF7 CCNL1	6.93e-04	194	40	3	5022c85ad3b137dae4b9ff11f9c23bb3bf4c0f5a
ToppCell	10x_3'_v3-spleen_(10x_3'_v3)-lymphocytic-T_lymphocytic-type_I_NK_T_cell\|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	MACF1 GPATCH8 SRSF7	7.04e-04	195	40	3	0a72b8446399807ace5b6c72f865bb40dbd9e92d
ToppCell	10x5'v1-week_14-16-Lymphocytic_B-B_lineage-pro_B_progenitor\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	BEST3 EIF2AK3 ZRANB2	7.04e-04	195	40	3	dc84a910b6f6eb9994cd683aa4fd813a82198e5f
ToppCell	(1)_T_cells-(1)_T_CD4_naive\|(1)_T_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1)	SETD2 NKTR ZRANB2	7.04e-04	195	40	3	d3fa551bc6f5ee5890af1040415e61ecd5d46201
ToppCell	10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-RG-RG\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	PIMREG SRRM4 RBMX	7.14e-04	196	40	3	0364a75fb831a9bb43d3b3c9ca1d890f9a68d6ca
ToppCell	10x5'v1-week_12-13-Lymphocytic_B-B_lineage-pre_B_progenitor\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	BEST3 PIMREG RBMX	7.14e-04	196	40	3	6ba02b806d440eed45bad7616bf3b8be57034427
ToppCell	3'\|World / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SRSF7 RBMX CCNL1	7.14e-04	196	40	3	44007f0c14e0f0703f7ee715b8eababb4d80a8b5
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic\|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k)	NKTR GPATCH8 SRSF7	7.14e-04	196	40	3	a9157809122e6fc5783a291522f103bef30943e4
ToppCell	10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-RG-RG-D\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	PIMREG SRRM4 RBMX	7.14e-04	196	40	3	2e818e0dae640bf398bbbb0081ffa86297adc1c5
ToppCell	10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-RG\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	PIMREG SRRM4 RBMX	7.14e-04	196	40	3	eb9ccc90012069b55ca92fadeb54c5f9468e937a
ToppCell	Control-Classical_Monocyte-cMono_2\|Classical_Monocyte / Disease condition and Cell class	BCLAF1 LRRFIP1 CCNL1	7.25e-04	197	40	3	eb7610c9496a95a5fd866e16abcbc39b83abe617
ToppCell	normal_Lymph_Node-Myeloid_cells-CD1c+_DCs\|Myeloid_cells / Location, Cell class and cell subclass	CHD1 LRRFIP1 CCNL1	7.25e-04	197	40	3	2b3cd318c988364adcba4441444045914d58fe46
Computational	Genes upregulated in subsets of cells of a given type within various tumors	CCNL2 LENG8 MACF1 NKTR SPEN	3.25e-07	50	32	5	GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_4
Computational	Genes upregulated in subsets of cells of a given type within various tumors	MACF1 SETD2 SPEN	4.27e-04	50	32	3	GAVISH_3CA_MALIGNANT_METAPROGRAM_4_CHROMATIN
Drug	AC1NRA5C	CCNL2 SREK1 SRSF7 CDK12 RBMX CCNL1 ZRANB2	2.03e-08	174	40	7	CID005287709
Drug	H-7 dihydrochloride; Down 200; 100uM; MCF7; HT_HG-U133A	CHD1 SRSF7 RBBP6 EIF2AK3 CCNL1	1.94e-05	189	40	5	5936_DN
Drug	2-propylpentanoic acid; Down 200; 1000uM; MCF7; HT_HG-U133A_EA	SREK1 SRSF7 SPEN CDK12 GOSR1	2.10e-05	192	40	5	1047_DN
Drug	Harmol hydrochloride monohydrate [40580-83-4]; Down 200; 15.8uM; MCF7; HT_HG-U133A	GAS2L1 SETD2 NKTR SRSF7 VAV2	2.20e-05	194	40	5	2900_DN
Disease	breast milk measurement	PPARGC1A CACNG4 GOSR1	3.20e-04	106	37	3	EFO_0009092
Disease	Libman-Sacks Disease	PCNX3 PHRF1	2.42e-03	58	37	2	C0242380
Disease	phospholipids:total lipids ratio, intermediate density lipoprotein measurement	MACF1 HNF4A	3.21e-03	67	37	2	EFO_0008595, EFO_0020946
Disease	Lupus Erythematosus, Systemic	PCNX3 PHRF1	3.60e-03	71	37	2	C0024141
Disease	Corneal astigmatism	PPARGC1A VAV2	4.22e-03	77	37	2	EFO_1002040
Disease	thalamus volume	PPARGC1A MACF1	5.12e-03	85	37	2	EFO_0006935
Disease	upper face morphology measurement	MACF1 RBMX	6.61e-03	97	37	2	EFO_0010949
Disease	Prostatic Neoplasms	SETD2 CHD1 SPEN CDK12	7.20e-03	616	37	4	C0033578
Disease	Malignant neoplasm of prostate	SETD2 CHD1 SPEN CDK12	7.20e-03	616	37	4	C0376358
Disease	cholesteryl esters:total lipids ratio, intermediate density lipoprotein measurement	MACF1 HNF4A	7.42e-03	103	37	2	EFO_0008595, EFO_0020944

Protein segments in the cluster

Peptide	Gene	Start	Entry
SSPRRRSYRRQTSDS	BEST3	406	Q8N1M1
SRRRSSSYERSGSYS	CDK12	306	Q9NYV4
EASPYVRSRERTSSS	EIF2AK3	791	Q9NZJ5
RSRSGTYSSRSRSRS	CCNL1	416	Q9UK58
TYSSRSRSRSRSHSE	CCNL1	421	Q9UK58
RSRRYSGSDSDSISE	CHD1	1091	O14646
SSRDYPSSRDTRDYA	RBMX	221	P38159
STRDGRRDRYSSDTT	GOSR1	41	O95249
RRSYDRSSRSLDQDS	KIAA1109	3821	Q2LD37
STDSRSRSSSRSPTR	LENG8	416	Q96PV6
RISTRRSSYEDSSLP	HNF4A	136	P41235
RSYSRDRSRSTRSPS	GPATCH8	986	Q9UKJ3
SPASSLRSQRRYSTD	PCNX3	431	Q9H6A9
TRSESRDRSSRSASP	PHRF1	1021	Q9P1Y6
RRSSGISPYFSSRRS	GLI2	821	P10070
RSRREAAFRSPYSST	PIMREG	176	Q9BSJ6
RSERSYRSERSGSLS	MACF1	21	Q9UPN3
RSGSTRSRSYSRSFS	RBBP6	706	Q7Z6E9
RSCSRSPYSRSRSRS	PPARGC1A	576	Q9UBK2
SGSYSRSRSRSCSRS	CHERP	761	Q8IWX8
SCSRSYSRSRSRSRS	CHERP	771	Q8IWX8
RRSRSSSRSTEASPS	CACNG4	241	Q9UBN1
RSRSRSREQSYSRSP	CCNL2	381	Q96S94
PRSRRYSGDSDSSAS	GAS2L1	346	Q99501
RSYRSSRSPRSSSSR	BCLAF1	131	Q9NYF8
RYSRRSRRNTSASDE	LRRFIP1	56	Q32MZ4
SSRDYPSSRDTRDYA	RBMXL1	221	Q96E39
YSDRSSESSPRSRSR	NKTR	681	P30414
SESSPRSRSRSSRSR	NKTR	686	P30414
YTRSRSLASSHSRSR	NKTR	706	P30414
SSYRSRSYSRSRSRG	NKTR	1346	P30414
RTSSRSRSRSSSYDP	NKTR	1381	P30414
SRSRSSSYDPHSRSR	NKTR	1386	P30414
SYYSRSRSRSRSQRS	NKTR	1406	P30414
RRSRSCRSYGSDSES	NKTR	1431	P30414
RSYNASRRSRSSSRE	SREK1	366	Q8WXA9
SRGPSCSRSRSRSRY	SRSF8	136	Q9BRL6
SRRRSSSDTAAYPAG	SETD1A	216	O15047
RLPSDSERRLYSRSS	SPEN	746	Q96T58
SERRLYSRSSDRSGS	SPEN	751	Q96T58
RPRSRSYSSTSIEEA	REPS2	456	Q8NFH8
SRSPYKARDRSRSRS	SRRM5	416	B3KS81
SRSSRSRRSPSYSRY	SRRM4	446	A7MD48
SSRSASRSYSRSRSR	SRRM4	541	A7MD48
GSRYFQSPSRSRSRS	SRSF7	186	Q16629
RGSRTNLSYSRSERS	SETD2	411	Q9BYW2
RRTSSHSSSYRDLRT	SETD2	471	Q9BYW2
RRRSSSSSSSDSRTY	RSRC1	21	Q96IZ7
SYDRRRRHRSSSSSS	RSRC1	61	Q96IZ7
SQRRRRTYSDTDSCS	PLEKHA3	236	Q9HB20
KRSYSSSSSSPERNR	ZRANB2	271	O95218
PYKSRERSASRASSR	VAV2	766	P52735
SSRSRSSCAREAYPV	WDR27	481	A2RRH5
PSAYRRVTETRSSFS	NEFM	11	P07197